Learning The Hard Way: Imperial Tobacco Group plc And AstraZeneca plc

Shareholders of Imperial Tobacco Group plc (LON:IMT) and AstraZeneca plc (LON:AZN) are similarly troubled, argues this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It is decision time for shareholders of Imperial Tobacco Group (LSE: IMT) and AstraZeneca (LSE: AZN) (NYSE: AZN.US). What do they have in common? As M&A talk fade away, these equity investments show clear signs of distress. Read on…

AstraZeneca: More Downside astrazeneca2

It takes a huge leap of faith to remain invested in Astra these days. The company isn’t likely to deliver growth for a couple of years, although Astra says its revenue growth will outpace that of competitors in the next decade.

A Footsie-beating dividend yield of 4% is not enough to render Astra stock an appealing buy in the current market. Indeed, its shares look overvalued based on forward trading multiples for cash flow and earnings. 

In mid-July I noted that ever since takeover talk vanished, Astra had struggled to create value, adding that Astra shareholders wouldn’t get the deal they had hoped for. The stock has lost about 4% of value in five weeks of trading and is on its way down to the end of the year, in my view.

When volatility surged in recent weeks Astra stock came under pressure, and I think downside of more than 10% is apparent, particularly if trading conditions get tough. And if volatility remains subdued, I don’t expect a market-beating performance to the end of the year.

It’s unlikely that Astra shareholders will be able to record a massive paper gain without a bid from Pfizer, and it’s conceivable that Pfizer will look elsewhere in weeks ahead. Astra shares still trade about 19% above Astra’s unaffected share price of £35.8 on 3 January.

Imperial Tobacco: A Dividend Play 

Imperial Tobacco reported interim results on Tuesday. Its shares rose 2.2% on the day, outperforming the broader market by more than one percentage point. The results made for a decent reading, but I was not impressed. Growth sputters, and that’s a big problem for Imperial shareholders. 

british american tobacco / imperial tobacco

Imperial stock have lost 5.8% of value from the all-time high it recorded in mid-July.  

The rise in Imperial’s equity valuation, which was spurred by takeover rumours earlier this year, came as investors decided to bet on Imperial as soon as it became apparent that consolidation was back on the agenda in the tobacco industry. Without a takeover — which is unlikely to take place — the stock of Imperial won’t be a winner in the next six months, in my view. 

Moreover, I think Imperial is a more appealing leveraged-buyout target than a takeover candidate for trade buyers. Taking it private for four years would make a lot of sense, but would require a substantial equity financing of up to 50% of the purchase price. If anything, Imperial’s latest nine-month results show that it may become more difficult for other players in the industry to meet estimates. 

In fact, guidance for the year continues “to be modest adjusted earnings per share growth” at constant currency, the group said. Imperial is a dividend play, given that it promises a dividend growth of at least 10%.

Much of its fortunes, however, hinge on a cost cutting programme which is forecast to deliver additional savings of £60m annually. In a tough regulatory environment for tobacco, nicotine and related products, this is how value will be pursued in the next few quarters. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »